[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336973-105":59,"doc-detail-336973-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","ror2-regulates-cellular-plasticity-in-pancreatic-neoplasia-and-adenocarcinoma","ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma","","Cellular plasticity is a defining feature of pancreatic ductal adenocarcinoma (PDAC), spanning conversion from normal cells to precancerous lesions and progression to aggressive, therapy-responsive subtypes. The study identifies that normal acinar differentiation maintained by PDX1 suppresses broad gastric cell identity programs preserved during metaplasia and neoplasia. ROR2 is discovered as a marker and functional regulator of a gastric metaplasiability-like state. Removing Ror2 promotes persistence of a gastric pit-cell identity, while ROR2 activity counteracts this fate, drives epithelial-to-mesenchymal transition, and affects sensitivity to KRAS and AKT pathway inhibition.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ror2-regulates-cellular-plasticity-in-pancreatic-neoplasia-and-adenocarcinoma/336973/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ror2-regulates-cellular-plasticity-in-pancreatic-neoplasia-and-adenocarcinoma/336973.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-20","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the central focus regarding ROR2 and pancreatic cancer?","Question",{"text":113,"@type":114},"The research identifies ROR2 as a regulator of cellular identity during pancreatic precancerous lesions and PDAC, linking its activity to aggressive phenotype and therapy resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does ROR2 loss affect cellular identity in mouse models?",{"text":118,"@type":114},"Ablation of Ror2 promotes a switch to a gastric pit cell identity in pancreatic tumorigenesis, and this identity persists through progression to the classical PDAC subtype.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic implications are suggested by ROR2 activity?",{"text":122,"@type":114},"ROR2 activity antagonizes the gastric pit-cell identity, promotes epithelial-to-mesenchymal transition, confers resistance to KRAS inhibition, and creates vulnerability to AKT inhibition, implying ROR2 targeting could enhance targeted therapy sensitivity.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336973,1790154963,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","ReseaRch aRticle  \nROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and  \nAdenocarcinoma   \nSimone Benitz1, Alec Steep2, Malak M. Nasser1, Jonathan Preall3, Ujjwal Mukund Mahajan4,  \nHolly McQuithey1, Ian Loveless5, Erick T. Davis1, Hui-Ju Wen1, Daniel W. Long1, Thomas Metzler6, Samuel Zwernik1, Michaela Louw1, Donald Rempinski1, Daniel J. Salas-Escabillas1, Sydney M. Brender1, Linghao Song2, Ling Huang1, Brian K. Theisen7, Zhenyu Zhang2, Nina G. Steele1,8,9, 10, Ivonne Regel4, Filip Bednar11, and Howard C. Crawford1,9, 10  \nCellular plasticity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) starting  \nfrom the conversion of normal cells into precancerous lesions, to the progression of carcinoma subtypes associated with aggressiveness and therapeutic response. We discovered that normal acinar cell differentiation, maintained by the transcription factor PDX1, suppresses a broad gastric cell identity that is maintained in metaplasia, neoplasia, and the classical subtype of PDAC in a mouse and human. We identified the receptor tyrosine kinase ROR2 as marker of a gastric metaplasialike identity in pancreas neoplasms. Ablation of Ror2 in a mouse model of pancreatic tumorigenesis promoted a switch to a gastric pit cell identity that largely persisted through progression to the classical subtype of PDAC. In both human and mouse pancreatic cancer, ROR2 activity continued to antagonize the gastric pit cell identity, strongly promoting an epithelial to mesenchymal transition, conferring resistance to KRAS inhibition, and vulnerability to AKT inhibition.  \nSigNifiCANCe: We discovered the receptor tyrosine kinase ROR2 as an important regulator of cellular identity in pancreatic precancerous lesions and pancreatic cancer. ROR2 drives an aggressive PDAC phenotype and confers resistance to KRAS inhibitors, suggesting that targeting ROR2 will enhance sensitivity to this new generation of targeted therapies.  \nSee related commentary by Marasco and Misale, p. 2018  \nintRoduction  \nPancreatic ductal adenocarcinoma (PDAC) is a deadly disease with few curative options for the vast majority of patients, in part because early detection methods are lacking. PDAC is marked by extensive tumor cell heterogeneity comprised of“classical” and “basal-like” molecular subtypes that, instead of acting as stable cellular communities, exist on a spectrum, with plasticity between subtypes likely contributing to therapeutic resistance (1–3) . Cellular plasticity is a hallmark of pancreatic cancer throughout progression, including transdifferentiation of normal cells into precancerous metaplastic and neoplastic lesions accompanied by the acquisition of distinct cellular identities. Whether cellular plasticity in precancerous disease is reflected in late-stage cancer progression has not been thoroughly considered, though some studies suggest a connection (4, 5) .  \n1Department of Surgery, Henry Ford Health, Detroit, Michigan. 2Center of Translational Data Science, University of Chicago, Chicago, Illinois. 3Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, New York.  \n4Department of Medicine II, University Hospital, LMU Munich, Munich, Germany. 5Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan. 6Comparative Experimental Pathology (CEP), Institute of Pathology, School of Medicine and Health, Technical University of Munich, Munich, Germany. 7Department of Pathology, Henry Ford Health, Detroit, Michigan. 8Department of Pathology, Wayne State University, Detroit, Michigan. 9Department of Pharmacology and Toxicology, Michigan State University, Lansing, Michigan. 10Department of Oncology, Wayne State University, Detroit, Michigan. 11Department of Surgery, University of Michigan, Ann Arbor, Michigan.  \nCorresponding Author: Howard C. Crawford, Department of Surgery, Henry  \nFord Health System, Detroit, MI 48202. E-mail: [hcrawfo1@hfhs.org](hcrawfo1@hfhs.org)  \nCancer Discov 2024;14:2162–82  \ndoi: 10. 1158/2159-8290","cbCaimH0rx9Dy1lp","https://ap.wps.com/l/cbCaimH0rx9Dy1lp","pdf",13019890,21,"English","# Introduction\n## Cellular plasticity in PDAC progression\n## Acinar-to-ductal metaplasia and ductal heterogeneity\n## KRAS-driven transformation and the role of acinar identity\n# Significance","[{\"question\":\"What is the central focus regarding ROR2 and pancreatic cancer?\",\"answer\":\"The research identifies ROR2 as a regulator of cellular identity during pancreatic precancerous lesions and PDAC, linking its activity to aggressive phenotype and therapy resistance.\"},{\"question\":\"How does ROR2 loss affect cellular identity in mouse models?\",\"answer\":\"Ablation of Ror2 promotes a switch to a gastric pit cell identity in pancreatic tumorigenesis, and this identity persists through progression to the classical PDAC subtype.\"},{\"question\":\"What therapeutic implications are suggested by ROR2 activity?\",\"answer\":\"ROR2 activity antagonizes the gastric pit-cell identity, promotes epithelial-to-mesenchymal transition, confers resistance to KRAS inhibition, and creates vulnerability to AKT inhibition, implying ROR2 targeting could enhance targeted therapy sensitivity.\"}]","ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma | PDF",1790017260,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5566af7e21c904830d9ea28e4ea125d8.webp",983,1315,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/185e18b8495407d9f5537cbafafeb47a.webp",982,1314,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9abf3681cb217dbc13de4e0a8a7c02e.webp",981,1312,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0891f342a8bff8225cee3132bc574be8.webp",980,1311]